Provided by Tiger Trade Technology Pte. Ltd.

Tenax Therapeutics

1.84
-0.2900-13.62%
Post-market: 1.82-0.0200-1.09%19:08 EDT
Volume:17.22M
Turnover:32.04M
Market Cap:68.86M
PE:-1.25
High:2.11
Open:2.11
Low:1.73
Close:2.13
52wk High:19.40
52wk Low:1.31
Shares:37.42M
Float Shares:17.52M
Volume Ratio:2.75
T/O Rate:98.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4685
EPS(LYR):-1.3412
ROE:-59.80%
ROA:-37.70%
PB:0.61
PE(LYR):-1.37

Loading ...

Tenax Therapeutics initiated with a Buy at Canaccord

TIPRANKS
·
Jul 28

Canaccord Genuity Initiates Tenax Therapeutics at Buy With $35 Price Target

MT Newswires Live
·
Jul 28

Tenax Therapeutics Initiated at Outperform by Evercore ISI Group

Dow Jones
·
Jul 22

Tenax Therapeutics (TENX) Gets a Buy from LifeSci Capital

TIPRANKS
·
Jul 11

Analysts Are Bullish on These Healthcare Stocks: Marker Therapeutics (MRKR), Tenax Therapeutics (TENX)

TIPRANKS
·
Jul 10

LifeSci Capital Reaffirms Their Buy Rating on Tenax Therapeutics (TENX)

TIPRANKS
·
Jul 06

Tenax Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 03

Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 03

Wall Street Set to Open Higher in Thursday Trading; US Adds Only 57,000 Jobs in June

MT Newswires Live
·
Jul 02

Tenax Therapeutics is Maintained at Buy by Chardan Capital

Dow Jones
·
Jul 02

Tenax Therapeutics highlights key Phase 3 LEVEL trial

TIPRANKS
·
Jul 02

Tenax Therapeutics Flags Announcement on LEVEL Trial Data Presentation at ESC Congress 2026

Reuters
·
Jul 02

Tenax Therapeutics Announces Late-breaking Presentation of Level Clinical Trial Data at Esc Congress 2026

THOMSON REUTERS
·
Jul 02

Tenax Therapeutics: Extends US Regulatory Approval Deadline to December 31, 2035 Via Sixth Amendment to Orion License - SEC Filing

THOMSON REUTERS
·
Jul 01

Tenax Signs Oral Levosimendan Supply Deal with Orion

Reuters
·
Jul 01

Tenax Therapeutics Updates Executive and Employee Severance Protections

TIPRANKS
·
Jun 30

Tenax Therapeutics Amends Executive Employment Agreements to Expand Severance, Change-in-control Benefits

Reuters
·
Jun 30

Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX), Biohaven Ltd. (BHVN) and BioLife Solutions (BLFS)

TIPRANKS
·
Jun 25

Tenax Therapeutics Price Target Maintained with a $35.00/share by Cantor Fitzgerald

Dow Jones
·
Jun 24

Tenax Therapeutics Initiated at Buy by Chardan Capital

Dow Jones
·
Jun 22